Grifols, S.A. (GRFS)
NASDAQ: GRFS · IEX Real-Time Price · USD
6.79
+0.36 (5.60%)
At close: May 1, 2024, 4:00 PM
6.73
-0.06 (-0.88%)
After-hours: May 1, 2024, 7:18 PM EDT

Grifols Revenue

In the year 2023, Grifols had annual revenue of $7.32B with 13.54% growth.

Revenue (ttm)
$7.32B
Revenue Growth
+13.54%
P/S Ratio
0.78
Revenue / Employee
$308,565
Employees
23,737
Market Cap
5.72B USD

Revenue Chart

* The company reports in EUR currency but revenue data is shown in USD.

History

Fiscal Year End Revenue Change Growth
Dec 31, 20237.32B873.39M13.54%
Dec 31, 20226.45B845.21M15.08%
Dec 31, 20215.61B-906.43M-13.92%
Dec 31, 20206.51B783.38M13.67%
Dec 31, 20195.73B571.71M11.09%
Dec 31, 20185.16B-24.74M-0.48%
Dec 31, 20175.18B919.81M21.58%
Dec 31, 20164.26B-11.34M-0.27%
Dec 31, 20154.27B213.59M5.26%
Dec 31, 20144.06B289.49M7.68%
Dec 31, 20133.77B313.07M9.06%
Dec 31, 20123.46B1.13B48.73%
Dec 31, 20112.32B999.88M75.49%
Dec 31, 20101.32B15.20M1.16%
Dec 31, 20091.31B174.54M15.38%
Dec 31, 20081.13B--
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
Option Care Health 4.43B
Bausch + Lomb 4.15B
R1 RCM 2.25B
Halozyme Therapeutics 829.25M
Ionis Pharmaceuticals 787.65M
Apellis Pharmaceuticals 396.59M
Glaukos 314.71M
Blueprint Medicines 249.38M
Revenue Rankings